Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuyen Bujnicki

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Scientific Reports|September 12, 2025
Artifact detection in fluorescence microscopy using convolutional autoencoderFabian Rehn, Marlene Pils, Tuyen Bujnicki, et al.
Scientific Reports|August 22, 2024
IAPP - oligomerisation levels in plasma of people with type 2 diabetesFabian Rehn, Victoria Kraemer-Schulien, Tuyen Bujnicki, et al.
Cell Reports. Medicine|May 18, 2022
Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivoBettina Kass, Sarah Schemmert, Christian Zafiu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 16, 2017
Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathiesYvonne Herrmann, Tuyen Bujnicki, Christian Zafiu, et al.
ACS Chemical Neuroscience|July 3, 2024
A Snake Venom Peptide and Its Derivatives Prevent Aβ<sub>42</sub> Aggregation and Eliminate Toxic Aβ<sub>42</sub> Aggregates <i>In Vitro</i>Luana Cristina Camargo, Ian Gering, Mohammadamin Mastalipour, et al.
Nature Communications|May 5, 2025
Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trialJanine Kutzsche, Nicoleta Carmen Cosma, Gunther Kauselmann, et al.
Diagnostics (Basel, Switzerland)|May 27, 2023
Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer's DiseaseMarlene Pils, Alexandra Dybala, Fabian Rehn, et al.
Biological Chemistry|November 5, 2016
Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assayKateryna Kravchenko, Andreas Kulawik, Maren Hülsemann, et al.
Clinical Biochemistry|November 9, 2016
sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body fluidsYvonne Herrmann, Andreas Kulawik, Katja Kühbach, et al.
NPJ Parkinson'S Disease|February 2, 2023
Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stoolAnja Schaffrath, Sophia Schleyken, Aline Seger, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Scientific Reports|September 12, 2025
Artifact detection in fluorescence microscopy using convolutional autoencoderFabian Rehn, Marlene Pils, Tuyen Bujnicki, et al.
Scientific Reports|August 22, 2024
IAPP - oligomerisation levels in plasma of people with type 2 diabetesFabian Rehn, Victoria Kraemer-Schulien, Tuyen Bujnicki, et al.
Cell Reports. Medicine|May 18, 2022
Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivoBettina Kass, Sarah Schemmert, Christian Zafiu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 16, 2017
Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathiesYvonne Herrmann, Tuyen Bujnicki, Christian Zafiu, et al.
ACS Chemical Neuroscience|July 3, 2024
A Snake Venom Peptide and Its Derivatives Prevent Aβ<sub>42</sub> Aggregation and Eliminate Toxic Aβ<sub>42</sub> Aggregates <i>In Vitro</i>Luana Cristina Camargo, Ian Gering, Mohammadamin Mastalipour, et al.
Nature Communications|May 5, 2025
Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trialJanine Kutzsche, Nicoleta Carmen Cosma, Gunther Kauselmann, et al.
Diagnostics (Basel, Switzerland)|May 27, 2023
Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer's DiseaseMarlene Pils, Alexandra Dybala, Fabian Rehn, et al.
Biological Chemistry|November 5, 2016
Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assayKateryna Kravchenko, Andreas Kulawik, Maren Hülsemann, et al.
Clinical Biochemistry|November 9, 2016
sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body fluidsYvonne Herrmann, Andreas Kulawik, Katja Kühbach, et al.
NPJ Parkinson'S Disease|February 2, 2023
Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stoolAnja Schaffrath, Sophia Schleyken, Aline Seger, et al.
Pageof 2